ConvaTec Group (LON:CTEC – Get Free Report) had its price objective cut by stock analysts at Royal Bank of Canada from GBX 320 ($4.12) to GBX 305 ($3.92) in a research report issued on Wednesday, LSE.Co.UK reports. The brokerage presently has an “outperform” rating on the stock. Royal Bank of Canada’s price objective suggests a potential upside of 29.35% from the company’s current price.
A number of other research firms have also weighed in on CTEC. JPMorgan Chase & Co. lowered their target price on shares of ConvaTec Group from GBX 323 ($4.15) to GBX 290 ($3.73) and set an “overweight” rating on the stock in a report on Wednesday. Berenberg Bank reaffirmed a “buy” rating and issued a GBX 310 ($3.99) price objective on shares of ConvaTec Group in a research report on Tuesday, June 11th. Six investment analysts have rated the stock with a buy rating, According to data from MarketBeat.com, the company currently has an average rating of “Buy” and a consensus target price of GBX 302.50 ($3.89).
ConvaTec Group Stock Down 0.6 %
ConvaTec Group Company Profile
ConvaTec Group PLC engages in the development, manufacturing, and sale of medical products, services, and technologies in Europe, North America, and internationally. The company offers advanced wound dressings and skin care products for the management of acute and chronic wounds resulting from various conditions, such as diabetes, and acute conditions resulting from traumatic injury and burns.
Read More
- Five stocks we like better than ConvaTec Group
- 3 Must-Buy Warren Buffett Stocks for Volatile Times
- Joby Aviation Stock: The Case for Upside Just Got Stronger
- CD Calculator: Certificate of Deposit Calculator
- Conviction Firms for Microsoft’s Double-Digit Stock Upside
- Do Real Estate Investment Trusts Deserve a Place in Your Portfolio?
- 5 Aggressive Growth Stocks for Long-Term Investors
Receive News & Ratings for ConvaTec Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for ConvaTec Group and related companies with MarketBeat.com's FREE daily email newsletter.